Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-19
1995-09-19
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548448, 548449, A61K 3140, C07D40706, C07D40712, C07D40702
Patent
active
054516005
ABSTRACT:
Compounds of the formula ##STR1## wherein R is hydrogen, alkyl.sub.1-8, geminal alkyl.sub.1-3, unsubstituted or substituted aryl; X is alkylene, --CR.sub.1 .dbd.CR.sub.2 -- (E and/or Z), carbonyl, oxygen or sulfur, wherein one of R.sub.1 and R.sub.2 is alkyl.sub.1-3 and the other is hydrogen; Y is unsubstituted alkyl.sub.1-12 or substituted by one or more alkyl.sub.1-3 groups, or unsubstituted or substituted phenylalkyl .sub.1-3 ; or a salt thereof with a pharmaceutically acceptable base, are described.
The compound of formula I are potent inhibitors of phospholipase A.sub.2 (PLA.sub.2) and are therefore useful in the treatment of inflammatory diseases, such as, psoriasis, inflammatory bowel disease, asthma, allergy, arthritis, dermatitis, gout, pulmonary, myocardial ischemia and trauma induced inflammation, such as, spinal cord injury.
Banner Bruce L.
Weber Giuseppe F.
Gerstl Robert
Gould George M.
Hoffmann-La Roche Inc.
Johnston George W.
Silverman Robert A.
LandOfFree
Substituted tetrahydrobenzopyrrolylfuranoic acid derivatives as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydrobenzopyrrolylfuranoic acid derivatives as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydrobenzopyrrolylfuranoic acid derivatives as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1828456